Stem cells and regenerative medicine on the Asian horizon: an economic, industry and social perspective.
For the past decade, forays into stem cell research and regenerative medicine by institutes and companies based in the Asia-Pacific region have attracted global attention at levels unprecedented in the life sciences. The unique combination of economic pressures, competitiveness and opportunism, laissez-faire regulation, burgeoning investment in the life sciences and rapidly growing markets, coupled with its great diversity, have propelled the region to surge forward in some areas, but to stumble in others. This article provides a historical and scientific context to the state of stem cell research and clinical applications in the region, and highlights trends and new possibilities to watch for on the Asian horizon.
Sipp
Douglas
D
RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minamimachi, Chuo-ku, Kobe, 650-0047, Japan. sipp@cdb.riken.jp
D001208:Asia; D035843:Biomedical Research / Q000191:economics*; D006801:Humans; D044968:Regenerative Medicine / Q000191:economics*; D012944:Social Support; D013234:Stem Cells / Q000502:physiology*